ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FDBK Feedback Plc

60.50
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 2,500 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 14851 to 14873 of 14875 messages
Chat Pages: 595  594  593  592  591  590  589  588  587  586  585  584  Older
DateSubjectAuthorDiscuss
10/7/2024
16:13
Ged5 - Thanks for that - A 100 share company Shares of £1. but do not appear to have been paid. Creditors of some £63771. (Accounts to 31st May)
pugugly
10/7/2024
16:03
2 badly managed companies clutching at straws.
ducatiman
10/7/2024
15:43
So MedDream is made by a Lithuanian software company called Softneta, but their website makes no mention (so far as I can see) of South African Vertex in their list of international agents, be it in relation to SA or UK. Vertex seems not to mention MedDream directly on its website. Meanwhile, in September 23 NHS Digital had to put out a warning regarding 'vulnerabilities' in the product.Hmm.
davwal
10/7/2024
12:15
Doesn't look great!
ged5
10/7/2024
11:59
Well that announcement contained a surprise for me but perhaps it shouldn't have done so.

"As part of the Agreement, Vertex will licence the database capabilities of Feedback's legacy picture archiving communication system Cadran PACS, now with the MedDream Viewer, which will allow it to build a PACS proposition that will initially be sold in South Africa and other international markets including the UK, where it sells PACS. This is another example of the Company's strategy to generate licencing royalties from its legacy products."

I seem to remember FDBK saying they were moving away from PACS because of the growth opportunities and competition. Still, I guess they're only licencing the software.

"Cadran is Feedback's established Picture Archiving and Communications System (PACS) which facilitates the review of medical imaging studies by clinicians. It is a progressive and rigorously tested Class 1 medical device with a longstanding legacy of service at NHS institutions, such as the Royal Papworth Hospital. However, it is currently positioned in a competitive market that shows little opportunity for future growth." 10th July 2019

Not really paying too much attention but I've only just noticed the description of FDBK:-

Started out in 2021 as the specialist medical imaging technology company
Became the specialist clinical communication company later in that year after the launch of Carelocker.
The following year it became the frontline clinical technology company but went back to the specialist clinical communication company a few months later.
In May 2023 it became the clinical infrastructure specialists and has stayed up to today.
Been here on and off far too long considering it's a company not too sure of its direction. Probably keep a few just in case it does stumble onto something that will bring success.

Anyone know what's happening with Axial 3d, Quest or CVS?

ged5
03/7/2024
12:34
Doesn't take much to pull the pants down on this disaster.
digger2779
02/7/2024
18:57
SP less than before contract announcement. Perhaps some were expecting 5mln.
yump
01/7/2024
10:21
About time too. Hope the other pilots are ready for take off soon.
digger2779
01/7/2024
10:16
Thanks for posting - useful summary.
yump
01/7/2024
10:14
What we've had so far.

Pilots

Amersham in Buckinghamshire RNS Dec 2023
Pan regional across Buckinghamshire, Oxfordshire and Berkshire ICS ("BOB ICS") RNS Dec 2023
Medical Imaging Partnership ("MIP") RNS Feb 2024
Oldham CDC RNS Mar 2024

Contracts

Queen Victoria Hospital NHS Foundation Trust

Subscriptions

Northern Care Alliance (NCA) RNS Sept 2023
Royal Berkshire Hospital NHS Foundation Trust (RBH)RNS Sept 2023

ged5
01/7/2024
08:20
Just a trend up would do really.
yump
01/7/2024
07:47
1 year, £495k. Cashburn £3m PA. We need a few more like this Yump. It’s a start though.
ducatiman
01/7/2024
07:44
Everyone on holiday and switched off ?
yump
27/6/2024
17:38
QVH interim contract due to expire end June I believe. Do we know if the incumbent has been successful?
ducatiman
14/6/2024
16:01
Yes, an interesting time that the buying started. I guess it was looking a bit oversold.
ged5
14/6/2024
15:37
Nice grouping of buys LR2. Looks leaky. QVH interim contract about to finish. Or could just be a DCB.
ducatiman
14/6/2024
15:19
A fair bit of buying in the last hour. Are we a bit leaky?
lr2
14/6/2024
11:06
LR2- Thanks -
pugugly
13/6/2024
09:28
He should just go into politics or lecturing then he can waffle on for ever without needing to get results.

We’ve got an academic commentator in charge of a business

yump
12/6/2024
13:58
Dr Tom Oakley, CEO, Feedback Medical on the future of multi-disciplinary teams
lr2
11/6/2024
23:50
For Pug, if you are still interested in the security and robustness of Bleepa.
lr2
06/6/2024
22:21
Bleepa prioritizes security and information governance. Here are some key points regarding its robustness against hacking:

1. Secure Architecture:
Bleepa is a secure, encrypted, zero-footprint application.
No patient data is stored locally on any device.
It adheres to international standards, including ISO 13485, ISO 27001, and Cyber Essentials Plus.

2. UKCA-Accredited:
Bleepa is a UKCA-accredited clinical communications platform.
It meets stringent security and quality criteria.

3. GDPR Compliance:
Bleepa is GDPR compliant compared to unaccredited, non-secure platforms.
Patient data is handled securely.

4. Auditable Patient Record:
Clinical discussions within Bleepa are captured as part of the auditable patient record.

In summary, Feedback Medical has designed Bleepa with robust security measures to protect patient data and ensure safe communication among healthcare professionals.

lr2
06/6/2024
21:45
How robust is Bleepa against being hacked?
"Services disrupted as London hospitals hit by cyber-attack
Attack is having a ‘major impact’ on Guy’s and St Thomas’ NHS trust, and is understood to have also affected other hospitals"

pugugly
Chat Pages: 595  594  593  592  591  590  589  588  587  586  585  584  Older